Quay Pharma work with clients based throughout the world. Most of whom are working in drug development between the late preclinical stage and the end of Phase III trials. Most clients are introducing a new drug product, reformulating or repositioning an established one. They range in size from global pharmaceutical and biotechnology concerns to small virtual companies and academic institutions. Clients come to us for the advice, services, and expertise that will enable them to progress their drug in the most clinically effective, cost-effective and timely way.
'We really appreciate the work Quay has done to develop our product to date' - Biotech, California, USA
'We were very impressed with the way Quay managed our project. They really understood the challenges we faced and delivered us with a number of prototype formulations that we were able to test in the clinic. Without them, the drug product would not be progressing to the clinic' - Merck & Co, USA
'We have always been extremely impressed by the scientific knowledge within the Quay team and their creative thinking in addressing problems. We enjoy working with their team and look forward to collaborating again in the near future' - AstraZeneca, United Kingdom
'The level of scientific expertise at Quay is much greater than we have found at other, often larger CMOs' - Biotech Company, Germany
'It has always been a pleasure working with the Quay team. They have always shown a high level of expertise concerning formulation development. Our projects have been conducted very competently and they have also managed any changes to our programs, often at short notice' - Nabriva Therapeutics, Austria